FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026117066> ?p ?o ?g. }

• W2026117066 endingPage "2387" @default.
• W2026117066 startingPage "2383" @default.
• W2026117066 abstract "ObjectiveTo characterize hyperosmolarity-responsive genes in leiomyoma cells and determine whether gonadotropin-releasing hormone (GnRH) agonist treatment altered their expression.DesignLaboratory study.SettingUniversity hospital.Patient(s)None.Intervention(s)Cell culture under hypertonic conditions and with GnRH agonist treatment, RNA isolation, and real-time reverse-transcriptase polymerase chain reaction (RT-PCR).Main Outcome Measure(s)Expression of nuclear factor of activated T cells 5 (NFAT5), aldose reductase (AR), and sodium myo-inositol transporter 1 (SMIT) messenger RNA (mRNA) in immortalized leiomyoma and patient-matched myometrial cells.Result(s)Leiomyoma cells had increased basal expression of NFAT5 mRNA (1.7 ± 0.08-fold) compared with myometrial cells. The NFAT5 increased further in leiomyoma cells cultured under hyperosmolar conditions (3.0 ± 0.46-fold at 50 mM NaCl and 3.3 ± 0.48-fold at 100 mM NaCl). The NFAT5-regulated mRNA transcripts for AR and SMIT were increased in untreated leiomyoma cells compared with myometrial cells and further increased in leiomyoma cells exposed to osmotic stress. The NFAT5 transcripts were decreased with low-dose GnRH agonist treatment but increased with supraphysiologic doses.Conclusion(s)Expression of hyperosmolarity genes was increased in leiomyoma cells relative to myometrial cells. Pharmacologic concentrations of GnRH agonist decreased NFAT5 expression, suggesting that water flows out of leiomyoma cells at pharmacologic doses. To characterize hyperosmolarity-responsive genes in leiomyoma cells and determine whether gonadotropin-releasing hormone (GnRH) agonist treatment altered their expression. Laboratory study. University hospital. None. Cell culture under hypertonic conditions and with GnRH agonist treatment, RNA isolation, and real-time reverse-transcriptase polymerase chain reaction (RT-PCR). Expression of nuclear factor of activated T cells 5 (NFAT5), aldose reductase (AR), and sodium myo-inositol transporter 1 (SMIT) messenger RNA (mRNA) in immortalized leiomyoma and patient-matched myometrial cells. Leiomyoma cells had increased basal expression of NFAT5 mRNA (1.7 ± 0.08-fold) compared with myometrial cells. The NFAT5 increased further in leiomyoma cells cultured under hyperosmolar conditions (3.0 ± 0.46-fold at 50 mM NaCl and 3.3 ± 0.48-fold at 100 mM NaCl). The NFAT5-regulated mRNA transcripts for AR and SMIT were increased in untreated leiomyoma cells compared with myometrial cells and further increased in leiomyoma cells exposed to osmotic stress. The NFAT5 transcripts were decreased with low-dose GnRH agonist treatment but increased with supraphysiologic doses. Expression of hyperosmolarity genes was increased in leiomyoma cells relative to myometrial cells. Pharmacologic concentrations of GnRH agonist decreased NFAT5 expression, suggesting that water flows out of leiomyoma cells at pharmacologic doses." @default.
• W2026117066 created "2016-06-24" @default.
• W2026117066 creator A5016148637 @default.
• W2026117066 creator A5067088712 @default.
• W2026117066 creator A5071895047 @default.
• W2026117066 creator A5073440131 @default.
• W2026117066 creator A5075929706 @default.
• W2026117066 date "2011-06-01" @default.
• W2026117066 modified "2023-09-27" @default.
• W2026117066 title "Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells" @default.
• W2026117066 cites W1969018878 @default.
• W2026117066 cites W1986768904 @default.
• W2026117066 cites W1993649166 @default.
• W2026117066 cites W1997276794 @default.
• W2026117066 cites W2022779155 @default.
• W2026117066 cites W2024039068 @default.
• W2026117066 cites W2025293338 @default.
• W2026117066 cites W2031612910 @default.
• W2026117066 cites W2033899224 @default.
• W2026117066 cites W2045556698 @default.
• W2026117066 cites W2054670584 @default.
• W2026117066 cites W2055038354 @default.
• W2026117066 cites W2067035770 @default.
• W2026117066 cites W2073500252 @default.
• W2026117066 cites W2088727502 @default.
• W2026117066 cites W2091700826 @default.
• W2026117066 cites W2092879837 @default.
• W2026117066 cites W2093612217 @default.
• W2026117066 cites W2099002965 @default.
• W2026117066 cites W2108144590 @default.
• W2026117066 cites W2112225255 @default.
• W2026117066 cites W2113046777 @default.
• W2026117066 cites W2127942631 @default.
• W2026117066 cites W2131199931 @default.
• W2026117066 cites W2132611932 @default.
• W2026117066 cites W2140354392 @default.
• W2026117066 cites W2144987360 @default.
• W2026117066 cites W2149664287 @default.
• W2026117066 cites W2155119821 @default.
• W2026117066 cites W2168761912 @default.
• W2026117066 cites W2169086621 @default.
• W2026117066 cites W2264069562 @default.
• W2026117066 cites W2297593361 @default.
• W2026117066 cites W2314671558 @default.
• W2026117066 cites W4233879913 @default.
• W2026117066 cites W4256138746 @default.
• W2026117066 cites W80518653 @default.
• W2026117066 doi "https://doi.org/10.1016/j.fertnstert.2011.03.084" @default.
• W2026117066 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4120297" @default.
• W2026117066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21496801" @default.
• W2026117066 hasPublicationYear "2011" @default.
• W2026117066 type Work @default.
• W2026117066 sameAs 2026117066 @default.
• W2026117066 citedByCount "26" @default.
• W2026117066 countsByYear W20261170662012 @default.
• W2026117066 countsByYear W20261170662014 @default.
• W2026117066 countsByYear W20261170662015 @default.
• W2026117066 countsByYear W20261170662016 @default.
• W2026117066 countsByYear W20261170662017 @default.
• W2026117066 countsByYear W20261170662018 @default.
• W2026117066 countsByYear W20261170662019 @default.
• W2026117066 countsByYear W20261170662020 @default.
• W2026117066 countsByYear W20261170662022 @default.
• W2026117066 crossrefType "journal-article" @default.
• W2026117066 hasAuthorship W2026117066A5016148637 @default.
• W2026117066 hasAuthorship W2026117066A5067088712 @default.
• W2026117066 hasAuthorship W2026117066A5071895047 @default.
• W2026117066 hasAuthorship W2026117066A5073440131 @default.
• W2026117066 hasAuthorship W2026117066A5075929706 @default.
• W2026117066 hasBestOaLocation W20261170661 @default.
• W2026117066 hasConcept C104317684 @default.
• W2026117066 hasConcept C126322002 @default.
• W2026117066 hasConcept C134018914 @default.
• W2026117066 hasConcept C142724271 @default.
• W2026117066 hasConcept C150194340 @default.
• W2026117066 hasConcept C170493617 @default.
• W2026117066 hasConcept C2776363309 @default.
• W2026117066 hasConcept C2777230143 @default.
• W2026117066 hasConcept C2777795800 @default.
• W2026117066 hasConcept C2778575703 @default.
• W2026117066 hasConcept C2778894405 @default.
• W2026117066 hasConcept C2778938600 @default.
• W2026117066 hasConcept C55493867 @default.
• W2026117066 hasConcept C71315377 @default.
• W2026117066 hasConcept C71924100 @default.
• W2026117066 hasConcept C86803240 @default.
• W2026117066 hasConceptScore W2026117066C104317684 @default.
• W2026117066 hasConceptScore W2026117066C126322002 @default.
• W2026117066 hasConceptScore W2026117066C134018914 @default.
• W2026117066 hasConceptScore W2026117066C142724271 @default.
• W2026117066 hasConceptScore W2026117066C150194340 @default.
• W2026117066 hasConceptScore W2026117066C170493617 @default.
• W2026117066 hasConceptScore W2026117066C2776363309 @default.
• W2026117066 hasConceptScore W2026117066C2777230143 @default.
• W2026117066 hasConceptScore W2026117066C2777795800 @default.
• W2026117066 hasConceptScore W2026117066C2778575703 @default.
• W2026117066 hasConceptScore W2026117066C2778894405 @default.
• W2026117066 hasConceptScore W2026117066C2778938600 @default.

• next